tiprankstipranks
Nurix Therapeutics announces extension of collaboration with Gilead
PremiumThe FlyNurix Therapeutics announces extension of collaboration with Gilead
23d ago
Gilead announces FDA approval for Vemlidy sNDA
PremiumThe Fly
Gilead announces FDA approval for Vemlidy sNDA
28d ago
Gilead sees FY24 EPS reduction of 3c-4c from Xilio Therapeutics deal
PremiumThe Fly
Gilead sees FY24 EPS reduction of 3c-4c from Xilio Therapeutics deal
28d ago
Gilead completes acquisition of CymaBay
PremiumThe FlyGilead completes acquisition of CymaBay
1M ago
Gilead says CymaBay deal to lower 2024 EPS by $3.35-$3.45
PremiumThe Fly
Gilead says CymaBay deal to lower 2024 EPS by $3.35-$3.45
1M ago
Gilead to contact other potential bidders in light of recent media reports
PremiumThe Fly
Gilead to contact other potential bidders in light of recent media reports
1M ago
Gilead says Biktarvy demonstrates high rates of viral suppression
PremiumThe FlyGilead says Biktarvy demonstrates high rates of viral suppression
2M ago
Gilead, Merck announce Phase 2 data on islatravir-lenacapavir combination
PremiumThe Fly
Gilead, Merck announce Phase 2 data on islatravir-lenacapavir combination
2M ago
Merus to potentially receive $56M in deal with Gilead to discover antigens
PremiumThe Fly
Merus to potentially receive $56M in deal with Gilead to discover antigens
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100